Clinical Trial

Testing Treatment for Prostate Cancer

Study Description

Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer

The purpose of this study is to compare the effects of ablative therapy (radiation or surgery) to all sites of disease combined with standard treatments on prostate cancer, compared to the standard or usual treatments used to treat this disease.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Radiation - Ablative Radiation Therapy

Undergo stereotactic radiotherapy and/or surgery to all sites of disease (oligometastases and primary prostate if previously untreated).

Standard of care

Patients continue to receive their current planned systemic therapy at the discretion of the treating physician

Additional Information

Official Study Title

A Randomized Phase III Trial of Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer [PLATON]

Clinical Trial ID

NCT03784755

ParticipAid ID

aOYqgd